Texas Pharma Co. Settles Opioid Whistleblower Suit For $2.8M

Law360 (May 11, 2021, 5:29 PM EDT) -- A pharmacy services company has reached a $2.75 million settlement with the federal government to resolve a whistleblower lawsuit alleging that it allowed opioids and other controlled substances to be dispensed without a valid prescription over a three-year period, according to court documents unsealed Tuesday.

The May 5 agreement between AlixaRx LLC and the U.S. Department of Justice, filed in the Northern District of Georgia, also ended claims that AlixaRx billed Medicare Part D for claims that had already been reimbursed through claims paid to long-term care facilities under Medicare Part A. Texas-based AlixaRx, which dispenses prescription drugs and runs Golden Gate National...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!